Jamie Layland
Overview
Explore the profile of Jamie Layland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dang Q, Psaltis P, Burgess S, Chandrasekhar J, Mukherjee S, Kritharides L, et al.
Eur Heart J
. 2025 Mar;
PMID: 40049585
Background And Aims: Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome (ACS). Recent data suggest a harmful association of dual antiplatelet therapy compared with...
2.
Jolly S, dEntremont M, Lee S, Mian R, Tyrwhitt J, Kedev S, et al.
N Engl J Med
. 2024 Nov;
392(7):633-642.
PMID: 39555823
Background: Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. Methods: In this multicenter trial with a 2-by-2 factorial...
3.
Fiolet A, Poorthuis M, Opstal T, Amarenco P, Boczar K, Buysschaert I, et al.
EClinicalMedicine
. 2024 Oct;
76:102835.
PMID: 39431112
Background: Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes....
4.
Rehan R, Virk S, Wong C, Passam F, Layland J, Keech A, et al.
Heart
. 2024 Jun;
110(15):988-996.
PMID: 38925881
Background: Despite restoration of epicardial blood flow in acute ST-elevation myocardial infarction (STEMI), inadequate microcirculatory perfusion is common and portends a poor prognosis. Intracoronary (IC) thrombolytic therapy can reduce microvascular...
5.
dEntremont M, Tiong D, Sadeghirad B, McGrath B, Cioffi G, Garni T, et al.
Am J Cardiol
. 2024 May;
223:29-39.
PMID: 38768846
Evidence regarding the comparative efficacy of the different methods to determine the significance of coronary stenoses in the catheterization laboratory is lacking. We aimed to compare all available methods guiding...
6.
Nogic J, Mehta O, Tong D, Brown A, Layland J
Cardiol Ther
. 2023 Jul;
12(3):539-541.
PMID: 37410319
No abstract available.
7.
Nogic J, Kim J, Layland J, Cheng K, Dey D, Wong D, et al.
Cardiovasc Revasc Med
. 2023 Mar;
53:61-66.
PMID: 36863976
Purpose: Coronary inflammation is postulated as a driver of atherosclerosis and dysfunctional arterial healing which may trigger stent failure. Pericoronary adipose tissue (PCAT) attenuation, detected on computer tomography coronary angiography...
8.
Nogic J, Mehta O, Tong D, Brown A, Layland J
Cardiol Ther
. 2023 Feb;
12(1):183-184.
PMID: 36790680
No abstract available.
9.
Nogic J, Mehta O, Tong D, Brown A, Layland J
Cardiol Ther
. 2023 Jan;
12(1):171-181.
PMID: 36609745
Introduction: Colchicine, thought to exert its effect via reduction of inflammation, has recently been studied in patients following acute coronary syndromes (ACS). We performed a meta-analysis of all available randomized...
10.
Wong N, Dinh D, Brennan A, Batchelor R, Duffy S, Shaw J, et al.
Open Heart
. 2022 Oct;
9(2).
PMID: 36220310
Background: Renal impairment post-percutaneous coronary intervention (post-PCI) is a well-described adverse effect following the administration of contrast media. Within a large cohort of registry patients, we aimed to explore the...